Sun Pharmaceuticals reported INR69.07B in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aspen Pharmacare APN:SJ 9.4B 792M
Bharat Petroleum BPCL:IN 135.53B 23.82B
Cipla CIPLA:IN 31.14B 2.22B
Dr.Reddys Laboratories DRRD:IN 35.77B 535M
Jiangsu Hengrui Me. 600276:CH CH 4.57B 75.78M
Reliance Infra RELI:IN IR 623660M 35080M
Sh Fosun Pharma 600196:CH CH 4.47B 581.58M
Sun Pharmaceuticals SUNP:IN IR 69071.3M 3153.1M
UPL UPLL:IN 78.67B 17.24B